SLG
CELG

Stanley-Laman Group’s Celgene Corp CELG Stock Holding History

Stanley-Laman Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,970
Closed -$990K – 306
2019
Q3 		$990K Sell
9,970
-862
-8% -$81.9K 0.24% 132
2019
Q2 		$1M Buy
10,832
+368
+4% +$34.9K 0.24% 134
2019
Q1 		$987K Buy
10,464
+517
+5% +$45.2K 0.24% 131
2018
Q4 		$638K Sell
9,947
-371
-4% -$27.4K 0.18% 200
2018
Q3 		$923K Sell
10,318
-53
-0.5% -$4.68K 0.23% 134
2018
Q2 		$824K Buy
10,371
+811
+8% +$67.3K 0.19% 162
2018
Q1 		$853K Buy
9,560
+130
+1% +$12.5K 0.19% 147
2017
Q4 		$984K Buy
+9,430
New +$1.06M 0.21% 131
2017
Q1 		– Sell
-11,602
Closed -$1.34M – 305
2016
Q4 		$1.34M Buy
11,602
+1,246
+12% +$139K 0.42% 89
2016
Q3 		$1.08M Buy
10,356
+1,248
+14% +$135K 0.44% 66
2016
Q2 		$898K Buy
+9,108
New +$942K 0.35% 107
2016
Q1 		– Sell
-11,542
Closed -$1.38M – 378
2015
Q4 		$1.38M Buy
11,542
+1,325
+13% +$153K 0.24% 115
2015
Q3 		$1.1M Buy
10,217
+346
+4% +$42.9K 0.22% 113
2015
Q2 		$1.14M Buy
9,871
+581
+6% +$66.4K 0.21% 121
2015
Q1 		$1.07M Buy
9,290
+1,261
+16% +$151K 0.2% 127
2014
Q4 		$898K Buy
8,029
+1,338
+20% +$141K 0.17% 139
2014
Q3 		$634K Buy
6,691
+419
+7% +$37.8K 0.12% 169
2014
Q2 		$539K Buy
+6,272
New +$477K 0.1% 200

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Stanley-Laman Group's CELG Position: Q4 2019 in Review

Stanley-Laman Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,970 shares — an estimated $990K sold.

Stanley-Laman Group first reported a position in CELG in Q2 2014 and held it in 18 quarters. The position peaked at $1.38M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Stanley-Laman Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Stanley-Laman Group sold 9,970 Celgene Corp shares in Q4 2019, an estimated $990K.
  • Stanley-Laman Group first reported a position in Celgene Corp in Q2 2014 and held it in 18 quarters.
  • Stanley-Laman Group's Celgene Corp position peaked at $1.38M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.